Report Thumbnail
Product Code QY09141154892J3
Published Date 2024/7/16
QY Research
English103 PagesGlobal

Ophthalmic Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 ‐ Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code QY09141154892J3◆The Jul 2025 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/7/16
QY Research
English 103 PagesGlobal

Ophthalmic Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 ‐ Pharmaceutical_LifeSciense Market


Abstract

Summary

There are several diseases that can affect the eyes, and often, the kind of treatment required is medication that you put directly into them. It is called “ophthalmic” and often comes in the form of drops, gel or ointment.
The global market for Ophthalmic Medicine was estimated to be worth US$ 1897 million in 2023 and is forecast to a readjusted size of US$ 2545 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Medicine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ophthalmic Medicine by region & country, by Type, and by Application.
The Ophthalmic Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Medicine.
Market Segmentation
By Company
Novaliq
Shenyang Xingqi Pharmaceutical Co.,Ltd.
Zhejiang Shapuaisi Pharmaceutical
Chengdu Kanghong Pharmaceutical Group
Santen Pharmaceutica
Bausch Health
Alcon NV
Mentholatum
Segment by Type:
Eye Drops
Eye Ointment
Gelling Agent
Tablet
Injection
Segment by Application
Anti-fatigue and Dryness
Cataract
Anti-infective
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ophthalmic Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ophthalmic Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ophthalmic Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

  • 1 Market Overview

    • 1.1 Ophthalmic Medicine Product Introduction
    • 1.2 Global Ophthalmic Medicine Market Size Forecast
      • 1.2.1 Global Ophthalmic Medicine Sales Value (2019-2030)
      • 1.2.2 Global Ophthalmic Medicine Sales Volume (2019-2030)
      • 1.2.3 Global Ophthalmic Medicine Sales Price (2019-2030)
    • 1.3 Ophthalmic Medicine Market Trends & Drivers
      • 1.3.1 Ophthalmic Medicine Industry Trends
      • 1.3.2 Ophthalmic Medicine Market Drivers & Opportunity
      • 1.3.3 Ophthalmic Medicine Market Challenges
      • 1.3.4 Ophthalmic Medicine Market Restraints
    • 1.4 Assumptions and Limitations
    • 1.5 Study Objectives
    • 1.6 Years Considered

  • 2 Competitive Analysis by Company

    • 2.1 Global Ophthalmic Medicine Players Revenue Ranking (2023)
    • 2.2 Global Ophthalmic Medicine Revenue by Company (2019-2024)
    • 2.3 Global Ophthalmic Medicine Players Sales Volume Ranking (2023)
    • 2.4 Global Ophthalmic Medicine Sales Volume by Company Players (2019-2024)
    • 2.5 Global Ophthalmic Medicine Average Price by Company (2019-2024)
    • 2.6 Key Manufacturers Ophthalmic Medicine Manufacturing Base Distribution and Headquarters
    • 2.7 Key Manufacturers Ophthalmic Medicine Product Offered
    • 2.8 Key Manufacturers Time to Begin Mass Production of Ophthalmic Medicine
    • 2.9 Ophthalmic Medicine Market Competitive Analysis
      • 2.9.1 Ophthalmic Medicine Market Concentration Rate (2019-2024)
      • 2.9.2 Global 5 and 10 Largest Manufacturers by Ophthalmic Medicine Revenue in 2023
      • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Medicine as of 2023)
    • 2.10 Mergers & Acquisitions, Expansion

  • 3 Segmentation by Type

    • 3.1 Introduction by Type
      • 3.1.1 Eye Drops
      • 3.1.2 Eye Ointment
      • 3.1.3 Gelling Agent
      • 3.1.4 Tablet
      • 3.1.5 Injection
    • 3.2 Global Ophthalmic Medicine Sales Value by Type
      • 3.2.1 Global Ophthalmic Medicine Sales Value by Type (2019 VS 2023 VS 2030)
      • 3.2.2 Global Ophthalmic Medicine Sales Value, by Type (2019-2030)
      • 3.2.3 Global Ophthalmic Medicine Sales Value, by Type (%) (2019-2030)
    • 3.3 Global Ophthalmic Medicine Sales Volume by Type
      • 3.3.1 Global Ophthalmic Medicine Sales Volume by Type (2019 VS 2023 VS 2030)
      • 3.3.2 Global Ophthalmic Medicine Sales Volume, by Type (2019-2030)
      • 3.3.3 Global Ophthalmic Medicine Sales Volume, by Type (%) (2019-2030)
    • 3.4 Global Ophthalmic Medicine Average Price by Type (2019-2030)

  • 4 Segmentation by Application

    • 4.1 Introduction by Application
      • 4.1.1 Anti-fatigue and Dryness
      • 4.1.2 Cataract
      • 4.1.3 Anti-infective
    • 4.2 Global Ophthalmic Medicine Sales Value by Application
      • 4.2.1 Global Ophthalmic Medicine Sales Value by Application (2019 VS 2023 VS 2030)
      • 4.2.2 Global Ophthalmic Medicine Sales Value, by Application (2019-2030)
      • 4.2.3 Global Ophthalmic Medicine Sales Value, by Application (%) (2019-2030)
    • 4.3 Global Ophthalmic Medicine Sales Volume by Application
      • 4.3.1 Global Ophthalmic Medicine Sales Volume by Application (2019 VS 2023 VS 2030)
      • 4.3.2 Global Ophthalmic Medicine Sales Volume, by Application (2019-2030)
      • 4.3.3 Global Ophthalmic Medicine Sales Volume, by Application (%) (2019-2030)
    • 4.4 Global Ophthalmic Medicine Average Price by Application (2019-2030)

  • 5 Segmentation by Region

    • 5.1 Global Ophthalmic Medicine Sales Value by Region
      • 5.1.1 Global Ophthalmic Medicine Sales Value by Region: 2019 VS 2023 VS 2030
      • 5.1.2 Global Ophthalmic Medicine Sales Value by Region (2019-2024)
      • 5.1.3 Global Ophthalmic Medicine Sales Value by Region (2025-2030)
      • 5.1.4 Global Ophthalmic Medicine Sales Value by Region (%), (2019-2030)
    • 5.2 Global Ophthalmic Medicine Sales Volume by Region
      • 5.2.1 Global Ophthalmic Medicine Sales Volume by Region: 2019 VS 2023 VS 2030
      • 5.2.2 Global Ophthalmic Medicine Sales Volume by Region (2019-2024)
      • 5.2.3 Global Ophthalmic Medicine Sales Volume by Region (2025-2030)
      • 5.2.4 Global Ophthalmic Medicine Sales Volume by Region (%), (2019-2030)
    • 5.3 Global Ophthalmic Medicine Average Price by Region (2019-2030)
    • 5.4 North America
      • 5.4.1 North America Ophthalmic Medicine Sales Value, 2019-2030
      • 5.4.2 North America Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030
    • 5.5 Europe
      • 5.5.1 Europe Ophthalmic Medicine Sales Value, 2019-2030
      • 5.5.2 Europe Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030
    • 5.6 Asia Pacific
      • 5.6.1 Asia Pacific Ophthalmic Medicine Sales Value, 2019-2030
      • 5.6.2 Asia Pacific Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030
    • 5.7 South America
      • 5.7.1 South America Ophthalmic Medicine Sales Value, 2019-2030
      • 5.7.2 South America Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030
    • 5.8 Middle East & Africa
      • 5.8.1 Middle East & Africa Ophthalmic Medicine Sales Value, 2019-2030
      • 5.8.2 Middle East & Africa Ophthalmic Medicine Sales Value by Country (%), 2023 VS 2030

  • 6 Segmentation by Key Countries/Regions

    • 6.1 Key Countries/Regions Ophthalmic Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
    • 6.2 Key Countries/Regions Ophthalmic Medicine Sales Value
      • 6.2.1 Key Countries/Regions Ophthalmic Medicine Sales Value, 2019-2030
      • 6.2.2 Key Countries/Regions Ophthalmic Medicine Sales Volume, 2019-2030
    • 6.3 United States
      • 6.3.1 United States Ophthalmic Medicine Sales Value, 2019-2030
      • 6.3.2 United States Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
      • 6.3.3 United States Ophthalmic Medicine Sales Value by Application, 2023 VS 2030
    • 6.4 Europe
      • 6.4.1 Europe Ophthalmic Medicine Sales Value, 2019-2030
      • 6.4.2 Europe Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
      • 6.4.3 Europe Ophthalmic Medicine Sales Value by Application, 2023 VS 2030
    • 6.5 China
      • 6.5.1 China Ophthalmic Medicine Sales Value, 2019-2030
      • 6.5.2 China Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
      • 6.5.3 China Ophthalmic Medicine Sales Value by Application, 2023 VS 2030
    • 6.6 Japan
      • 6.6.1 Japan Ophthalmic Medicine Sales Value, 2019-2030
      • 6.6.2 Japan Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
      • 6.6.3 Japan Ophthalmic Medicine Sales Value by Application, 2023 VS 2030
    • 6.7 South Korea
      • 6.7.1 South Korea Ophthalmic Medicine Sales Value, 2019-2030
      • 6.7.2 South Korea Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
      • 6.7.3 South Korea Ophthalmic Medicine Sales Value by Application, 2023 VS 2030
    • 6.8 Southeast Asia
      • 6.8.1 Southeast Asia Ophthalmic Medicine Sales Value, 2019-2030
      • 6.8.2 Southeast Asia Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
      • 6.8.3 Southeast Asia Ophthalmic Medicine Sales Value by Application, 2023 VS 2030
    • 6.9 India
      • 6.9.1 India Ophthalmic Medicine Sales Value, 2019-2030
      • 6.9.2 India Ophthalmic Medicine Sales Value by Type (%), 2023 VS 2030
      • 6.9.3 India Ophthalmic Medicine Sales Value by Application, 2023 VS 2030

  • 7 Company Profiles

    • 7.1 Novaliq
      • 7.1.1 Novaliq Company Information
      • 7.1.2 Novaliq Introduction and Business Overview
      • 7.1.3 Novaliq Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
      • 7.1.4 Novaliq Ophthalmic Medicine Product Offerings
      • 7.1.5 Novaliq Recent Development
    • 7.2 Shenyang Xingqi Pharmaceutical Co.,Ltd.
      • 7.2.1 Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information
      • 7.2.2 Shenyang Xingqi Pharmaceutical Co.,Ltd. Introduction and Business Overview
      • 7.2.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
      • 7.2.4 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Offerings
      • 7.2.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Development
    • 7.3 Zhejiang Shapuaisi Pharmaceutical
      • 7.3.1 Zhejiang Shapuaisi Pharmaceutical Company Information
      • 7.3.2 Zhejiang Shapuaisi Pharmaceutical Introduction and Business Overview
      • 7.3.3 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
      • 7.3.4 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Offerings
      • 7.3.5 Zhejiang Shapuaisi Pharmaceutical Recent Development
    • 7.4 Chengdu Kanghong Pharmaceutical Group
      • 7.4.1 Chengdu Kanghong Pharmaceutical Group Company Information
      • 7.4.2 Chengdu Kanghong Pharmaceutical Group Introduction and Business Overview
      • 7.4.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
      • 7.4.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Offerings
      • 7.4.5 Chengdu Kanghong Pharmaceutical Group Recent Development
    • 7.5 Santen Pharmaceutica
      • 7.5.1 Santen Pharmaceutica Company Information
      • 7.5.2 Santen Pharmaceutica Introduction and Business Overview
      • 7.5.3 Santen Pharmaceutica Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
      • 7.5.4 Santen Pharmaceutica Ophthalmic Medicine Product Offerings
      • 7.5.5 Santen Pharmaceutica Recent Development
    • 7.6 Bausch Health
      • 7.6.1 Bausch Health Company Information
      • 7.6.2 Bausch Health Introduction and Business Overview
      • 7.6.3 Bausch Health Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
      • 7.6.4 Bausch Health Ophthalmic Medicine Product Offerings
      • 7.6.5 Bausch Health Recent Development
    • 7.7 Alcon NV
      • 7.7.1 Alcon NV Company Information
      • 7.7.2 Alcon NV Introduction and Business Overview
      • 7.7.3 Alcon NV Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
      • 7.7.4 Alcon NV Ophthalmic Medicine Product Offerings
      • 7.7.5 Alcon NV Recent Development
    • 7.8 Mentholatum
      • 7.8.1 Mentholatum Company Information
      • 7.8.2 Mentholatum Introduction and Business Overview
      • 7.8.3 Mentholatum Ophthalmic Medicine Sales, Revenue and Gross Margin (2019-2024)
      • 7.8.4 Mentholatum Ophthalmic Medicine Product Offerings
      • 7.8.5 Mentholatum Recent Development

  • 8 Industry Chain Analysis

    • 8.1 Ophthalmic Medicine Industrial Chain
    • 8.2 Ophthalmic Medicine Upstream Analysis
      • 8.2.1 Key Raw Materials
      • 8.2.2 Raw Materials Key Suppliers
      • 8.2.3 Manufacturing Cost Structure
    • 8.3 Midstream Analysis
    • 8.4 Downstream Analysis (Customers Analysis)
    • 8.5 Sales Model and Sales Channels
      • 8.5.1 Ophthalmic Medicine Sales Model
      • 8.5.2 Sales Channel
      • 8.5.3 Ophthalmic Medicine Distributors

  • 9 Research Findings and Conclusion

  • 10 Appendix

    • 10.1 Research Methodology
      • 10.1.1 Methodology/Research Approach
      • 10.1.2 Data Source
    • 10.2 Author Details
    • 10.3 Disclaimer
USD 3,950 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.